 


Aurinia Pharmaceuticals Inc. (AUPH)























 








Investors & Media
Careers
Contact Us

 












Home

About Us

Overview
Management Team
Board of Directors
Partnering

 
Our Focus
 
Our Medicine

Product
Patient Safety

 
For Patients/Physicians

Overview
Lupus Nephritis (LN)

 
Investors & Media


Careers


Contact Us






Investors & Media
Careers
Contact Us

 










Changing the course of autoimmune disease
Inspired by patients. Driven to make an impact. 













Aurinia’s Response to COVID-19 View










Latest News 


May 14, 2021 • 6:05am EDT
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Read Press Release
View All News




May 10, 2021 • 4:05pm EDT
Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis
Read Press Release
View All News




May 10, 2021 • 6:05am EDT
Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS™ (voclosporin) in The Lancet
Read Press Release
View All News












        			© 2021 Aurinia Pharmaceuticals Inc. All Rights Reserved.
        		










Privacy Statement
Terms of Use
Disclaimer
Aurinia Compliance Program
Sitemap











